Algert Global LLC Has $24.91 Million Stock Position in Astera Labs, Inc. $ALAB

Algert Global LLC lifted its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 117.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 127,212 shares of the company’s stock after purchasing an additional 68,822 shares during the period. Astera Labs accounts for about 0.4% of Algert Global LLC’s investment portfolio, making the stock its 21st biggest holding. Algert Global LLC owned approximately 0.08% of Astera Labs worth $24,908,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. increased its holdings in shares of Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after acquiring an additional 2,751,747 shares during the last quarter. Amundi grew its holdings in Astera Labs by 1,298.6% during the third quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Rafferty Asset Management LLC acquired a new position in Astera Labs during the third quarter valued at approximately $209,599,000. BNP Paribas Financial Markets raised its position in shares of Astera Labs by 577.3% in the third quarter. BNP Paribas Financial Markets now owns 1,127,340 shares of the company’s stock valued at $220,733,000 after purchasing an additional 960,899 shares during the period. Finally, 1832 Asset Management L.P. lifted its stake in shares of Astera Labs by 151.4% in the second quarter. 1832 Asset Management L.P. now owns 1,543,500 shares of the company’s stock worth $139,563,000 after buying an additional 929,600 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

Several analysts recently issued reports on ALAB shares. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective for the company. BNP Paribas Exane started coverage on shares of Astera Labs in a research report on Thursday, November 20th. They set an “outperform” rating for the company. Jefferies Financial Group restated a “buy” rating on shares of Astera Labs in a report on Wednesday, December 3rd. Northland Securities boosted their price objective on Astera Labs from $175.00 to $195.00 and gave the stock an “outperform” rating in a research report on Tuesday, December 9th. Finally, Raymond James Financial started coverage on Astera Labs in a research note on Friday, November 21st. They set a “hold” rating for the company. Fifteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $202.22.

Insider Buying and Selling at Astera Labs

In related news, CEO Jitendra Mohan sold 94,971 shares of the company’s stock in a transaction on Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total value of $11,758,359.51. Following the completion of the transaction, the chief executive officer directly owned 1,452,739 shares in the company, valued at approximately $179,863,615.59. This represents a 6.14% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, General Counsel Philip Mazzara sold 10,000 shares of the firm’s stock in a transaction on Monday, March 2nd. The stock was sold at an average price of $117.47, for a total value of $1,174,700.00. Following the completion of the transaction, the general counsel directly owned 128,084 shares of the company’s stock, valued at approximately $15,046,027.48. This trade represents a 7.24% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 224,292 shares of company stock valued at $27,676,069 in the last quarter. 12.50% of the stock is currently owned by corporate insiders.

Astera Labs Stock Performance

NASDAQ:ALAB opened at $120.31 on Friday. The firm’s 50-day moving average is $147.89 and its 200-day moving average is $168.11. The company has a market cap of $20.48 billion, a price-to-earnings ratio of 98.61, a PEG ratio of 2.37 and a beta of 1.74. Astera Labs, Inc. has a 52-week low of $47.13 and a 52-week high of $262.90.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million during the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a net margin of 25.70% and a return on equity of 16.12%. The firm’s revenue was up 91.8% on a year-over-year basis. During the same quarter last year, the company earned $0.37 earnings per share. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Equities analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current year.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.